Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma

Yuankai Shi, MD PhD, Mei Dong, MD, Jun Zhu, MD, Daobin Zhou, MD, Huiqiang Huang, MD, Ping Tu, MD, Weijing Zhang, MD, Xiaonan Hong, MD, Xielan Zhao, MD, Jianfang Sun, MD, Yuehua Liu, MD, Lugui Qiu, MD PhD, ZhiXiang Shen, MD, Jifeng Feng, MD, Xiaoyan Ke, MD PhD

Blood (2015) 126 (23): 1513.

https://doi.org/10.1182/blood.V126.23.1513.1513

Published: 2015

Journal Articles

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Yuankai Shi, MD PhD, Bo Jia, Xiaohui He, MD, Youwu Shi, Mei Dong, MD, Jianliang Yang, MD, Liqiang Zhou, MD, Shengyu Zhou, MD, Peng Liu, MD, Yan Qin, MD, Sheng Yang, MD, Hua Lin, MD, Lin Gui, MD, Changgong Zhang, MD, Lin Wang, MD, Shanshan Chen, MD, Puyuan Xing, MD, Hongnan Mo, MD, Mingzhe Han, MD

Blood (2015) 126 (23): 2718.

https://doi.org/10.1182/blood.V126.23.2718.2718

Published: 2015

Journal Articles

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Shaoxuan Hu, Xiaohui He, MD, Yuankai Shi, MD PhD, Sheng Yang, MD, Yan Qin, MD, Jianliang Yang, MD, Mei Dong, MD, Shengyu Zhou, MD, Peng Liu, MD, Lin Gui, MD, Changgong Zhang, MD, Liqiang Zhou, MD

Blood (2015) 126 (23): 5045.

https://doi.org/10.1182/blood.V126.23.5045.5045

Published: 2015

Journal Articles

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Jingjing Wang, Mei Dong, MD, Xiaohui He, MD, Weihu Wang, MD, Peng Liu, MD, Jianliang Yang, MD, Yan Qin, MD, Lin Gui, MD, Sheng Yang, MD, Yexiong Li, MD PhD, Yuankai Shi, MD PhD, Lugui Qiu, MD

Blood (2014) 124 (21): 3071.

https://doi.org/10.1182/blood.V124.21.3071.3071

Published: 2014

Journal Articles

miR-142-3p acts as an essential modulator of neutrophil development in zebrafish

Hong-Bo Fan, Yi-Jie Liu, Lei Wang, Ting-Ting Du, Mei Dong, Li Gao, Zhao-Zheng Meng, Yi Jin, Yi Chen, Min Deng, Huang-Tian Yang, Qing Jing, Ai-Hua Gu, Ting-Xi Liu, Yong Zhou

Blood (2014) 124 (8): 1320–1330.

https://doi.org/10.1182/blood-2013-12-545012

Published: 2014

Includes: Supplemental data

Journal Articles

Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis

Ting Zhou, Lei Wang, Kang-Yong Zhu, Mei Dong, Peng-Fei Xu, Yi Chen, Sai-Juan Chen, Zhu Chen, Min Deng, Ting Xi Liu

Blood (2011) 118 (14): 3842–3852.

https://doi.org/10.1182/blood-2010-12-327908

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

An evolutionarily conserved PTEN-C/EBPα-CTNNA1 axis controls myeloid development and transformation

Blood (2010) 115 (23): 4715–4724.

https://doi.org/10.1182/blood-2009-11-255778

Published: 2010

Includes: Supplemental data

Journal Articles

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

Giuseppe Saglio, Dong-Wook Kim, MD, PhD, Surapol Issaragrisil, MD, FRCP, FACP, FRCPA, FRCPath, Philipp D. le Coutre, MD, Josy Reiffers, MD, Clarisse Lobo, MD, Ricardo Pasquini, MD, Richard E. Clark, MD, Timothy P. Hughes, MD, MBBS, Andreas Hochhaus, MD, Neil J. Gallagher, MD, PhD, Albert Hoenekopp, MD, Mei Dong, MD, MS, Ariful Haque, MS, Hagop M. Kantarjian, MD, Richard A. Larson, MD

Blood (2009) 114 (22): LBA-1.

https://doi.org/10.1182/blood.V114.22.LBA-1.LBA-1

Published: 2009

Journal Articles

Mir-144 selectively regulates embryonic α-hemoglobin synthesis during primitive erythropoiesis

Yan-Fang Fu, Ting-Ting Du, Mei Dong, Kang-Yong Zhu, Chang-Bin Jing, Yong Zhang, Lei Wang, Hong-Bo Fan, Yi Chen, Yi Jin, Gui-Ping Yue, Sai-Juan Chen, Zhu Chen, Qiu-Hua Huang, Qing Jing, Min Deng, Ting Xi Liu

Blood (2009) 113 (6): 1340–1349.

https://doi.org/10.1182/blood-2008-08-174854

Published: 2009

Includes: Supplemental data

Journal Articles

Role of transforming growth factor-β in hematologic malignancies

Mei Dong, Gerard C. Blobe

Blood (2006) 107 (12): 4589–4596.

https://doi.org/10.1182/blood-2005-10-4169

Published: 2006

NARROW

Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

miR-142-3p acts as an essential modulator of neutrophil development in zebrafish

Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis

An evolutionarily conserved PTEN-C/EBPα-CTNNA1 axis controls myeloid development and transformation

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

Mir-144 selectively regulates embryonic α-hemoglobin synthesis during primitive erythropoiesis

Role of transforming growth factor-β in hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only